Anbio carries out the whole industry chain development layout from medical laboratory products to point-of-care test. Products cover technical platforms such as immunology, blood and molecular diagnosis, and meets the needs of clinical diagnosis through product integration.
Anbio (Xiamen) Biotechnology Co., Ltd. was established in 2015, focuses on the research, production, sales and service of in vitro diagnostic products. With POCT as the main development direction, POCT focuses on the accuracy, quickness and intelligence of clinical diagnosis, and develops rapidly in the field of market segmentation. The company has been rated as Xiamen high-tech enterprises, Xiamen science and technology-based small and medium-sized enterprises.
Adhere to the improvement of scientific and technological innovation ability and customer service ability, regard providing high-quality products and services for customers as the dignity and responsibility of enterprises, and regard human life and health as the driving force and direction of enterprises' continuous progress.
With strict and efficient management mode, excellence, continuous innovation, sustainable development of corporate value